Verition Fund Management
ORIC icon

Verition Fund Management’s Oric Pharmaceuticals ORIC Stock Holding History

Verition Fund Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-34,205
Closed -$276K – 3620
2024
Q4 		$276K Sell
34,205
-8,775
-20% -$80.5K ﹤0.01% 2816
2024
Q3 		$441K Buy
42,980
+8,752
+26% +$86.5K ﹤0.01% 2396
2024
Q2 		$242K Buy
+34,228
New +$306K ﹤0.01% 2482
2023
Q4 		– Sell
-24,400
Closed -$148K – 2605
2023
Q3 		$148K Buy
24,400
+20
+0.1% +$164 ﹤0.01% 2055
2023
Q2 		$189K Buy
24,380
+11,055
+83% +$62.8K ﹤0.01% 1874
2023
Q1 		$76K Buy
+13,325
New +$69.6K ﹤0.01% 1933

Other funds holding ORIC

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return